| Ms Carolyn E Smith, CRNA | |
|
2000 Ogden Ave, Aurora, IL 60504-7222 | |
| (630) 948-4860 | |
| Not Available |
| Full Name | Ms Carolyn E Smith |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 2000 Ogden Ave, Aurora, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417060682 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Carolyn E Smith, CRNA 185 Penny Ave, East Dundee, IL 60118-1454 Ph: (847) 836-7015 | Ms Carolyn E Smith, CRNA 2000 Ogden Ave, Aurora, IL 60504-7222 Ph: (630) 948-4860 |
News Archive
Joslin Diabetes Center and Ember Therapeutics, Inc. today announced an agreement aimed at utilizing "brown fat," a type of fat that helps increase energy expenditure within the body, as a novel technique for managing obesity and diabetes. Joslin's Chief Academic Officer, Dr. Ronald Kahn and other Joslin faculty, Drs. Yu-Hua Tseng and Aaron Cypess, have performed pioneering work in this field over the past several years, and were the first to show that a natural protein called BMP7 can help modulate the levels of brown fat.
The American Cancer Society estimates that 44,000 new cases of pancreatic cancer will be diagnosed this year and that 37,000 people will die from the disease. These are not strong odds. A new drug, rigosertib, allows pancreatic cancer cells to rush through replication - and then stops them cold, killing them in in the middle of a step called M phase. Healthy cells that don't rush are unharmed.
Inhibitex, Inc., announced today that it has successfully completed a Phase1a, first-in-man, single ascending dose trial of INX-189, its nucleotide polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV) infections. In this trial, 42 healthy volunteers received either a single oral dose of INX-189, ranging from 3 mg to 100 mg, or placebo. The Company plans to present detailed results from this trial during a future scientific meeting.
Particle Sciences and Microfluidics extended their collaboration with the placement of the newly-announced Microfluidics Reaction Technology system at Particle Sciences.
Here's another potential reason to live up in the mountains. Lung cancer rates in both smokers and non-smokers are lower in higher-elevation counties in the western part of the United States, suggesting that oxygen may promote the incidence of lung cancer, according to a new study co-authored by a student at the Perelman School of Medicine at the University of Pennsylvania.
› Verified 4 days ago
Florian Walter, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2000 Ogden Ave, Rush Copley Memorial Hospital, Aurora, IL 60504 Phone: 630-978-6200 | |
Ms. Ginger T. Guinther, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2000 Ogden Ave, Aurora, IL 60504 Phone: 630-978-4860 | |
John Fitzgerald, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: Provena Mercy Medical Center, 1325 N. Highland Ave., Aurora, IL 60506 Phone: 630-859-2222 | |
Arlene R. Garite, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1325 N Highland Ave, Provena Mercy Medical Center, Aurora, IL 60506 Phone: 630-859-2222 | |
Erin Dianne Browning, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2000 Ogden Ave, Aurora, IL 60504 Phone: 630-660-3796 | |
Mr. Segun Sadique Shonibare, CRNA, MS Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1325 N Highland Ave, Anesthesia Dept, Aurora, IL 60506 Phone: 630-859-2222 | |
Barbara J Partida, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2000 Ogden Ave, Aurora, IL 60504 Phone: 630-978-6200 |